XML 41 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value Measurements (Tables)
3 Months Ended
Apr. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value, Assets Measured on Recurring Basis
The following table presents the fair value hierarchy for the Company’s assets and liabilities measured at fair value on a recurring basis as of April 30, 2024 (in thousands):

Level 1
Level 2
Total
Assets:
Cash equivalents:
Money market funds$492,568 $— $492,568 
U.S. government securities— 367,493 367,493 
Time deposits— 58,145 58,145 
Commercial paper— 53,735 53,735 
Corporate notes and bonds— 34,411 34,411 
Short-term investments:
Corporate notes and bonds— 834,770 834,770 
Commercial paper— 528,048 528,048 
U.S. government and agency securities— 518,716 518,716 
Certificates of deposit— 319,401 319,401 
Long-term investments:
Corporate notes and bonds— 655,893 655,893 
U.S. government and agency securities— 260,402 260,402 
Certificates of deposit— 11,686 11,686 
Derivative assets:
Foreign currency forward contracts— 1,041 1,041 
Total assets$492,568 $3,643,741 $4,136,309 
Liabilities:
Derivative liabilities:
Foreign currency forward contracts$— $(1,512)$(1,512)
Total liabilities
$— $(1,512)$(1,512)
The following table presents the fair value hierarchy for the Company’s assets and liabilities measured at fair value on a recurring basis as of January 31, 2024 (in thousands):

Level 1
Level 2
Total
Assets:
Cash equivalents:
U.S. government securities$— $742,234 $742,234 
Money market funds533,211 — 533,211 
Time deposits— 56,263 56,263 
Short-term investments:
Corporate notes and bonds— 939,727 939,727 
U.S. government and agency securities— 573,780 573,780 
Commercial paper— 353,548 353,548 
Certificates of deposit— 216,444 216,444 
Long-term investments:
Corporate notes and bonds— 607,989 607,989 
U.S. government and agency securities— 299,637 299,637 
Certificates of deposit— 8,681 8,681 
Derivative assets:
Foreign currency forward contracts— 60 60 
Total assets$533,211 $3,798,363 $4,331,574 
Liabilities:
Derivative liabilities:
Foreign currency forward contracts$— $(745)$(745)
Total liabilities
$— $(745)$(745)
Schedule of Fair Value Measurements
The following table presents the Company’s strategic investments by type (in thousands):

April 30, 2024January 31, 2024
Equity securities:
Non-marketable equity securities under Measurement Alternative$198,579 $190,238 
Non-marketable equity securities under equity method5,388 5,307 
Marketable equity securities12,606 37,320 
Debt securities:
Non-marketable debt securities1,985 1,500 
Total strategic investments—included in other assets$218,558 $234,365 
Unrealized Gain (Loss) on Investments
The following table summarizes the gains and losses associated with the Company’s strategic investments in equity securities (in thousands):

Three Months Ended April 30,
20242023
Unrealized losses on non-marketable equity securities under Measurement Alternative:
Impairments$(18,753)$— 
Net unrealized losses on marketable equity securities
(3,655)(2,414)
Net unrealized losses on strategic investments in equity securities
(22,408)(2,414)
Net realized gains on marketable equity securities sold(1)
1,713 — 
Total—included in other expense, net$(20,695)$(2,414)
________________
(1)Represents the difference between the sale proceeds and the carrying value of the security at the beginning of the period or the purchase date, if later.
Realized Gain (Loss) on Investments
The following table summarizes the gains and losses associated with the Company’s strategic investments in equity securities (in thousands):

Three Months Ended April 30,
20242023
Unrealized losses on non-marketable equity securities under Measurement Alternative:
Impairments$(18,753)$— 
Net unrealized losses on marketable equity securities
(3,655)(2,414)
Net unrealized losses on strategic investments in equity securities
(22,408)(2,414)
Net realized gains on marketable equity securities sold(1)
1,713 — 
Total—included in other expense, net$(20,695)$(2,414)
________________
(1)Represents the difference between the sale proceeds and the carrying value of the security at the beginning of the period or the purchase date, if later.